I don't see how you can label Larry Holmes "an a.....e too" for simply quoting the "per Spec tives" newsletter's cautions about promotional machines, psychological wizard promoters/brokers and investor manipulation.(I do realize you a.....e comment was tongue in cheek and you clearly support his caution.) This newsletter, to which I subscribe, has a pretty good record of successful recommendations.
Unfortunately, Larry didn't give "per Spec tives" analysis summary of Notran which appears in the same issue from which he quoted. I post it for your consideration.
Nortran Pharmaceuticals (NRT)
nortran.com
We felt this stock was headed lower near term, and it has this week. That will have a foul taste in the mouths of shareholders, but the intensity of the run higher caused profit taking, despite having some excellent news. We don't think that this stock is headed too much lower, and we should see a bounce soon. 60%
Mr Forthright, this newsletter, to which you directed us, that stands on guard against promotional machines, psychological wizardry by brokers/promoters and investor manipulation, after appropriate due diligence, sees Nortran as an excellent news company with upside potential.
Regards, Ed |
